These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 27507394)

  • 1. Adverse drug reactions: classification, susceptibility and reporting.
    Kaufman G
    Nurs Stand; 2016 Aug; 30(50):53-63. PubMed ID: 27507394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
    Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
    Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse drug reaction reporting in the UK: a retrospective observational comparison of yellow card reports submitted by patients and healthcare professionals.
    McLernon DJ; Bond CM; Hannaford PC; Watson MC; Lee AJ; Hazell L; Avery A;
    Drug Saf; 2010 Sep; 33(9):775-88. PubMed ID: 20701410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying and managing adverse drug reactions: Qualitative analysis of patient reports to the UK yellow card scheme.
    O' Donovan B; Rodgers RM; Cox AR; Krska J
    Br J Clin Pharmacol; 2022 Jul; 88(7):3434-3446. PubMed ID: 35128732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pattern of adverse drug reactions notified by spontaneous reporting in an Indian tertiary care teaching hospital.
    Jose J; Rao PG
    Pharmacol Res; 2006 Sep; 54(3):226-33. PubMed ID: 16781163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonmedical prescriber experiences of training and competence to report adverse drug reactions in the UK.
    Thompson A; Randall C; Howard J; Barker C; Bowden D; Mooney P; Munyika A; Smith S; Pirmohamed M
    J Clin Pharm Ther; 2019 Feb; 44(1):78-83. PubMed ID: 30206951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse effects of neuromuscular blocking agents based on yellow card reporting in the U.K.: are there differences between males and females?
    Light KP; Lovell AT; Butt H; Fauvel NJ; Holdcroft A
    Pharmacoepidemiol Drug Saf; 2006 Mar; 15(3):151-60. PubMed ID: 16395661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse drug reactions in dermatology.
    Ferner RE
    Clin Exp Dermatol; 2015 Mar; 40(2):105-9; quiz 109-10. PubMed ID: 25622648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interpreting adverse drug reaction (ADR) reports as hospital patient safety incidents.
    Davies EC; Green CF; Mottram DR; Pirmohamed M
    Br J Clin Pharmacol; 2010 Jul; 70(1):102-8. PubMed ID: 20642552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Public awareness in Wales of the UK Yellow Card scheme for reporting suspected adverse drug reactions.
    Bracchi RC; Tseliou F; Copeland L; Routledge PA; Thomas A; Woods F; Adams A; Walker J; Jadeja M; Atkinson MD; Ashfield-Watt P
    Br J Clin Pharmacol; 2021 Aug; 87(8):3344-3348. PubMed ID: 33386761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse drug reactions and polypharmacy in the elderly in general practice.
    Veehof LJ; Stewart RE; Meyboom-de Jong B; Haaijer-Ruskamp FM
    Eur J Clin Pharmacol; 1999 Sep; 55(7):533-6. PubMed ID: 10501824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Under-reporting of adverse drug reactions: a challenge for pharmacovigilance in India.
    Tandon VR; Mahajan V; Khajuria V; Gillani Z
    Indian J Pharmacol; 2015; 47(1):65-71. PubMed ID: 25821314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Idiosyncratic adverse reactions of most frequent drug combinations longterm use among hospitalized patients with polypharmacy.
    Trumic E; Pranjic N; Begic L; Becic F; Asceric M
    Med Arch; 2012; 66(4):243-8. PubMed ID: 22919879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of hospital episodes with 'drug-induced' disorders and spontaneously reported adverse drug reactions.
    Barrow P; Waller P; Wise L
    Br J Clin Pharmacol; 2006 Feb; 61(2):233-7. PubMed ID: 16433879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A survey of spontaneous reporting of adverse drug reactions in 10 years of activity in a pharmacovigilance centre in Portugal.
    Marques J; Ribeiro-Vaz I; Pereira AC; Polónia J
    Int J Pharm Pract; 2014 Aug; 22(4):275-82. PubMed ID: 24188533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polypharmacy: the challenge for nurses.
    Kaufman G
    Nurs Stand; 2016 May; 30(39):52-60. PubMed ID: 27224631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse Effects of Common Drugs: General Concepts.
    Karpa KD; Lewis PR; Felix TM
    FP Essent; 2015 Sep; 436():11-6. PubMed ID: 26375993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Dealing with adverse drug reactions in dentistry. Procedures on encountering adverse drug reactions and goal of the Swiss Pharmacovigilance system].
    Egger SS; Krähenbühl S; Schlienger RG
    Schweiz Monatsschr Zahnmed; 2005; 115(12):1209-18. PubMed ID: 16408825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring drug safety in Astrakhan, Russia.
    Kirilochev OO; Dorfman IP; Umerova AR
    Int J Risk Saf Med; 2015; 27 Suppl 1():S33-4. PubMed ID: 26639700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Views of British community pharmacists on direct patient reporting of adverse drug reactions (ADRs).
    Krska J
    Pharmacoepidemiol Drug Saf; 2013 Oct; 22(10):1130-3. PubMed ID: 22729956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.